ASX-173
ASX-173 is an orally active asparagine synthetase (ASNS) inhibitor with an IC50 of 0.113 μM and a Ki of 0.4 nM. It enhances the anticancer activity of L-Asparaginase (ASNase) . When combined with ASNase, ASX-173 disrupts nucleotide synthesis and induces cell cycle arrest, apoptosis (apoptosis), and autophagy (autophagy) in leukemia cells. This combination also slows the growth of OCI-AML2 xenograft tumors. ASX-173 is applicable in research on acute lymphoblastic leukemia, acute myeloid leukemia, colorectal cancer, and other cancers.
Product Specifications
CAS Number
2748800-08-8
Field of Research
Cell Biology, Epigenetics & Chromatin, Molecular Biology, Protein Biochemistry, Signal Transduction
Smiles
C (NC (C1=CC=CC=C1) C2=CC=CC=C2) (=O) [C@@H]3N (C ([C@H] (CC) N) =O) C[C@H] ([C@@H]3O) C4=CC=C (F) C=C4
Molecular Formula
C28H30FN3O3
Molecular Weight
475.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Rabbit TACR3 (Tachykinin Receptor 3) ELISA Kit
Rabbit TACR3 (Tachykinin Receptor 3) ELISA Kit
Rabbit TACR3 (Tachykinin Receptor 3) ELISA Kit
Rabbit TACR3 (Tachykinin Receptor 3) ELISA Kit